Combined application of the selective TLR4 activator LPS and TAK242 or PDTC was introduced to determine the anti-inflammatory role of ATX based on the TLR4/MyD88/NF-κB pathway in the progression of burn-induced AKI. This evidence concerns the gene MYD88 and acute kidney injury.